–
Доклады на научных конференциях
-
- 2025 Proved clinical benefit of low-dose anti-CTLA4 + anti-PD-1 immunotherapy versus mono anti-PD-1 therapy in patients unresectable or metastatic melanoma: Phase III OCTAVA trial (Стендовый)
- Авторы: Demidov Lev, Samoylenko Igor, Kharkevich Galina, Orlova Kristina, Moiseenko Vladimir, Utyashev Igor, Stroyakovskiy Daniil, Kozlov Vadim, Mochalova Anastasia, Demidova Svetlana, Lyadova Marina, Kutkovich Andrey, Skopin Pavel, Kovalenko Nadezhda, Safina Sufia, Volkov Vitaliy, Semiletova Yulia, Vaschenko Vera, Kislov Nikolaiy, Poltoratsky Artem, Shumskaya Irina, Kolomiets Sergey, Sobolev Alexander, Belogortsev Igor, Odintsova Svetlana, Rastogi Sameer, Andabekov Timur, Zimina Anastasia, Penkov Konstantin, Semenova Anna, Obukhov Alexey, Belyakovsky Vasiliy, Gladkov Oleg, Neve Rakesh, Falaleeva Natalia, Poddubskaya Elena, Vaibhav Amale, Kirtbaya Dmitriy, Chapko Yana, Smagina Maria, Sorokina Irina, Linkova Yulia, Zinkina-Orikhan Arina, Kriukov Fedor, Lutsky Anton, Mikhailova Evgenia
- AACR ANNUAL MEETING 2025, McCormick Place Convention Center Chicago, Illinois, США, 25-30 апреля 2025